Plant Health Care PLC
19 September 2005
Embargoed until 7am 19 September 2005
Plant Health Care plc
License Agreement
Plant Health Care ('PHC' or the 'Group') is pleased to announce that it has
entered into a licensing agreement with Eden Bioscience for the use of Eden's
next generation Harpin technology. Harpins are proteins that elicit a growth
response when applied to plants. Under the terms of the agreement PHC will have
exclusive rights for a minimum of 5 years (subject to minimum purchase
requirements) to use Harpin technology in nutritional products in the UK, the
Netherlands and Scandinavia, and non-exclusive rights to sell those products in
Northern Africa and Italy. PHC has the right to test these products in Mexico
and the US to determine their market potential.
PHC has developed a product trademarked Pre-Tect which combines Harpin with
some of PHC's proprietary natural based technologies. In trials, Pre-Tect has
been shown to consistently increase the yield and the shelf life of leaf crops,
such as lettuce, spinach and broccoli, for 2 to 5 days.
The Group is currently in discussions with certain supermarket chains in the UK
concerning the possibility of Pre-Tect being used by their growers and suppliers
in order to reduce their product wastage.
John Brady, CEO of Plant Health Care, said, 'The incorporation of Eden's next
generation Harpin technology into PHC's product portfolio is a very exciting
addition for the Group. Our Pre-Tect product has consistently increased yield
and shelf life on leaf crops and by using Pre-Tect as one of their regular
cropping inputs grocers can address one of the most significant problems that
they face, namely the limited shelf life of fresh produce. PHC'S Pre-Tect will
allow the grocers to naturally add shelf life, limit losses due to spoilage and,
as a result, increase profits.
For further information please contact:
Plant Health Care plc
John Brady, CEO Tel: 001 603 525 3702
Eden Bioscience
Rhett Atkins, CEO Tel: 001 425 806 7300
Tavistock Communications Tel: 020 7920 3150
Jeremy Carey
Christian Taylor-Wilkinson
Notes to Editors:
About Plant Health Care
Plant Health Care plc ('PHC') is a leading provider of natural products for
plants and soil. Established in 1995 in Pittsburgh (Pennsylvania) in the United
States, PHC currently has approximately 60 employees and has operations in the
US, Mexico, UK, Spain, and the Netherlands with technical support in Austria.
The Group has two principal operating subsidiaries in the US - PHC Inc (PA) and
PHC-REC. The Company listed on the AIM market of the London Stock Exchange in
July 2004. Ticker symbol is phc.
PHC's products are aimed at the horticulture, agriculture, turf grass,
commercial landscaping, forestry and land reclamation industries and are both
environmentally beneficial and on the whole more cost effective than synthetic
chemical alternatives. Through the commercialisation of these products, PHC is
capitalising on current long-term trends toward natural systems and biological
products for plant care and soil and water management uses.
PHC-REC is an environmental and reclamation engineering consulting firm which
provides engineering and design services for reclamation lands disturbed by
mining, construction, and other activities. PHC-REC is the recognised leader in
the use of biologically based solutions using mycorrhizal fungi and bacteria for
the establishment of trees, shrubs, and grasses on these disturbed lands.
PHC-REC was established in 1997 to exploit PHC's products and technology.
Web Site: www.planthealthcare.com
About Eden Bioscience
Eden Bioscience was founded in 1994 and is located in Bothell, Washington USA.
The company is primarily engaged in the sales and marketing of its proprietary
Harpin technology. Eden's technology is based on a family of naturally occurring
proteins called 'harpins' and represents a unique type of crop production tool
Eden classifies as plant health regulators.
Web site: www.edenbio.com
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.